Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021

SELL
$15.39 - $18.97 $720,252 - $887,796
-46,800 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$17.1 - $19.19 $800,280 - $898,092
46,800 New
46,800 $835,000
Q2 2020

Aug 14, 2020

SELL
$14.59 - $19.5 $640,617 - $856,206
-43,908 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$13.02 - $20.31 $571,682 - $891,771
43,908 New
43,908 $667,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $42.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.